Mechanisms of the endothelium-dependent relaxation induced by NG-hydroxy-L-arginine
- PMID: 1282987
- DOI: 10.1097/00005344-199204002-00017
Mechanisms of the endothelium-dependent relaxation induced by NG-hydroxy-L-arginine
Abstract
There are three mechanisms by which NG-hydroxy-L-arginine (L-HOArg) induces endothelium-dependent relaxations. L-HOArg is a substrate for the constitutive nitric oxide (NO) synthase present in endothelial cells (ECs). It reacts with NO released from EC to form a potent and more stable vasodilator. Moreover, it induces a relatively stable, EC-dependent relaxation that is not blocked by the inhibitors of NO synthesis. Subsequently, we have investigated the effects of hydroxyguanidine (HOG) on the biological activity of endothelium-derived relaxing factor (EDRF). HOG potentiated the relaxant responses of rabbit aortic strips to EDRF released from EC by adenosine diphosphate (ADP) or bradykinin as well as those induced by authentic NO. Importantly, it was not a substrate for NO synthesis and it did not affect the generation of prostacyclin by ECs. Thus, the effects of HOG were due to the chemical reaction of HOG with NO released from ECs and the formation of a more stable vasodilator. Moreover, HOG augmented not only agonist-triggered, but also flow-induced, EC-dependent relaxation and both effects of HOG were abolished by NG-nitro-L-arginine methyl ester (L-NO2-Arg). In contrast, the EC-dependent relaxation induced by L-HOArg was not inhibited by L-NO2Arg. Moreover, it was not affected by the removal of extracellular Ca2+, but was blocked by oxyhemoglobin and potentiated by superoxide dismutase. These results demonstrate the involvement of the hydroxyguanidino moiety of L-HOArg in its reaction with NO. Moreover, they strongly support the notion that nitrix oxide mediates both the agonist-triggered and flow-induced endothelium-dependent relaxation.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Potentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium-derived relaxing factor.Br J Pharmacol. 1992 Dec;107(4):1001-7. doi: 10.1111/j.1476-5381.1992.tb13398.x. Br J Pharmacol. 1992. PMID: 1281716 Free PMC article.
-
NG-hydroxy-L-arginine and hydroxyguanidine potentiate the biological activity of endothelium-derived relaxing factor released from the rabbit aorta.Biochem Biophys Res Commun. 1992 Dec 15;189(2):711-6. doi: 10.1016/0006-291x(92)92259-z. Biochem Biophys Res Commun. 1992. PMID: 1472042
-
Nitric oxide and another potent vasodilator are formed from NG-hydroxy-L-arginine by cultured endothelial cells.Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11172-6. doi: 10.1073/pnas.88.24.11172. Proc Natl Acad Sci U S A. 1991. PMID: 1662386 Free PMC article.
-
Evidence for the existence of a constitutive nitric oxide synthase in vascular smooth muscle.Clin Exp Pharmacol Physiol. 2002 Aug;29(8):725-7. doi: 10.1046/j.1440-1681.2002.03707.x. Clin Exp Pharmacol Physiol. 2002. PMID: 12100009 Review.
-
Role of endothelium-formed nitric oxide on vascular responses.Gen Pharmacol. 1990;21(5):575-87. doi: 10.1016/0306-3623(90)91002-9. Gen Pharmacol. 1990. PMID: 2276579 Review.
Cited by
-
Involvement of nitric oxide in the endothelium-dependent relaxation induced by hydrogen peroxide in the rabbit aorta.Br J Pharmacol. 1993 Sep;110(1):151-8. doi: 10.1111/j.1476-5381.1993.tb13785.x. Br J Pharmacol. 1993. PMID: 7693274 Free PMC article.
-
Oxidative denitrification of N omega-hydroxy-L-arginine by the superoxide radical anion.Biochem J. 1996 Jul 1;317 ( Pt 1)(Pt 1):17-21. doi: 10.1042/bj3170017. Biochem J. 1996. PMID: 8694760 Free PMC article.
-
Biological significance of agmatine, an endogenous ligand at imidazoline binding sites.Br J Pharmacol. 2001 Jul;133(6):755-80. doi: 10.1038/sj.bjp.0704153. Br J Pharmacol. 2001. PMID: 11454649 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous